Jane Street’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Jane Street’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,900	Closed	-$158K	–	11290
2021 Q4	$158K	Sell	54,900 -25,100	-31%	-$92.8K	﹤0.01%	8972
2021 Q3	$339K	Buy	80,000 +35,400	+79%	+$158K	﹤0.01%	7952
2021 Q2	$236K	Sell	44,600 -57,000	-56%	-$274K	﹤0.01%	8565
2021 Q1	$472K	Buy	+101,600	New	+$461K	﹤0.01%	6905

Jane Street's ZYNE Position: Q4 2023 in Review

Jane Street sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 282,478 shares — an estimated $360K sold.

Jane Street first reported a position in ZYNE in Q2 2018 and held it in 14 quarters. The position peaked at $466K in Q2 2020. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Jane Street reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Jane Street sold 282,478 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $360K.
Jane Street first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2018 and held it in 14 quarters.
Jane Street's Zynerba Pharmaceuticals, Inc position peaked at $466K in Q2 2020.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.